The purpose of the Digital Pathology Association Reimbursement Task Force is to support the market access of digital pathology solutions globally and drive the value of whole slide imaging (WSI) and AI-based algorithms. The key objectives of the task force are:

  • Drive and shape the model for reimbursement for WSI and AI-based image analysis
  • Support increased market access for DP solutions globally
  • Be the trusted resource (single point of contact) for reimbursement/market access issues for digital pathology
  • Create uniformity in communication around reimbursement for digital pathology solutions
  • Map the reimbursement environment globally and set the strategy for DPA influence

Participation in this Task Force is open to Benefactor member representatives only.

Committee Members


Co-Chair: Michael Rivers + Giovanni Lujan


  • Esther Abels, MSc, SolarisRTC LLC
  • James Almas, Labcorp
  • Jennifer Archer, MPP, Artera
  • Pascal Bamford, Akoya Biosciences
  • Scott Blakely, Hamamatsu Corporation
  • Nick Brown, PathAI
  • Nathan Buchbinder, Proscia Inc.
  • Joseph Chiweshe, MD MPH, Leica Biosystems
  • Dana Dilbeck, Agilent
  • Christopher Garcia, MD, Mayo Clinic
  • Kimberly Gasuad, Ibex Medical Analytics
  • Paul Gerrard, Artera
  • Emre Gulturk, Paige
  • Nicholas Halzack, Roche
  • Raymond Jenoski, MS, Hologic, Inc.
  • David Klimstra, MD, Paige
  • Erick Lin, MD, PhD, MBA, Ibex Medical Analytics
  • Steven Lott, PhD, MB(ASCP), Lott Consulting
  • Giovanni Lujan, MD, Ohio State University Wexner Medical Center
  • Mike Montalto, PhD, PathAI
  • Anil Parwani, MD, PhD, MBA, The Ohio State University Wexner Medical Center
  • Kim Rendon, Proscia Inc.
  • Michael Rivers, Roche
  • Jennifer Samboy, MHA, Philips
  • Elizabeth Sheppard, HT(ASCP) MBA, AstraZeneca
  • Rajendra Singh, MD, Summit Health
  • Thomas Westerling-Bui, PhD, Aiforia
  • Michelle Wynn, Hologic, Inc.
  • Joe Yeh, MD, aetherAI